Your contact

Gabriele Klingner

Communications & Marketing Lead

Christiane Proll

PR & Social Media Manager

Newsletter

Newsletter
The free BioM newsletter contains news from the biotech industry in Munich and Bavaria, as well as information on events and funding programs for the life sciences. The BioM newsletter is published every two weeks. You can unsubscribe at any time.

Post press release

Post press release

BioRN Annual Conference 2024 - 15% discount for our community

We are happy to offer our network 15% discount for the BioRN Annual Conference 2024 on October 9 in Heidelberg. The BAC 2024 combines high-calibre presentations with a wide range of networking opportunities on the topic New Therapeutic Modalities in Personalised Medicine

Be part of the BioRN Annual Conference (BAC) 2024 - where expertise from basic, applied and clinical research will be shared and new perspectives and visions will be introduced.

In addition young scientists will present their cutting edge research in the "Young Scientists Pitch Competition". The conference will be complemented by an exhibition area where companies and institutions present their latest technologies and products.

Thanks to groundbreaking technological advancements, radiopharmaceuticals and antibody drug conjugates have once more opened up remarkable capabilities towards clinical development. In addition, new insights in epigenetics, RNA biology, and molecular glues have unveiled avenues for other novel therapeutic modalities holding great promise for individual treatments.

The BioRN Annual Conference will bring together expertise in basic, applied and clinical research in these fields, fostering new perspectives and visions for personalized medicine.

Discount:
Thanks to our partnership, take advantage of 15% discount for our BioM
If you are interested, please contact BioM (Dr. Max Pöhlmann, poehlmann@remove-this.bio-m.org or Gabriele Klingner, klingner@remove-this.bio-m.org).

Register here for the BioRN Annual Conference "New Therapeutic Modalities in Personalised Medicine".